021-51111890
购物车（）
sales@molnova.cn
BI-6C9
CAS No. 791835-21-7
BI-6C9 ( —— )
产品货号. M20490 CAS No. 791835-21-7
BI-6C9 是 tBid 的抑制剂 (Kd = 20 μM)。BI-6c9 阻止 MOMP 和线粒体裂变，并保护细胞免于细胞死亡。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥713 | 有现货 |
|
| 5MG | ￥1191 | 有现货 |
|
| 10MG | ￥2001 | 有现货 |
|
| 25MG | ￥3710 | 有现货 |
|
| 50MG | ￥5492 | 有现货 |
|
| 100MG | ￥7825 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BI-6C9
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述BI-6C9 是 tBid 的抑制剂 (Kd = 20 μM)。BI-6c9 阻止 MOMP 和线粒体裂变，并保护细胞免于细胞死亡。
-
产品描述BI-6C9 is an inhibitor of tBid (Kd = 20 μM).BI-6c9 prevented MOMP and mitochondrial fission and protected the cells from cell death.
-
体外实验Cell Viability Assay Cell Line:HT-22 cells Concentration:10 μM Incubation Time:18 hours Result:Attenuated Glutamate-induced cell death.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体tBid
-
研究领域——
-
适应症——
化学信息
-
CAS Number791835-21-7
-
分子量471.59
-
分子式C23H25N3O4S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 250 mg/mL (530.12 mM)
-
SMILESCOc1ccc(cc1)S(=O)(=O)NCCCC(=O)Nc1ccc(Sc2ccc(N)cc2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Grohm J Plesnila N Culmsee C . Bid mediates fission membrane permeabilization and peri-nuclear accumulation of mitochondria as a prerequisite for oxidative neuronal cell death[J]. Brain Behavior and Immunity 2010 24(5):0-838.
产品手册
关联产品
-
Isorhamnetin 3-O-api...
Isorhamnetin 3-O-apiosyl (1->2)[rhamnosyl (1->6)]glucoside
-
1-N-Methyl-4-mercapt...
1-N-Methyl-4-mercaptohistidine disulfide is a potential Duchenne chloroplast coupling factor 1 redox regulator, an oxidized form of ochratoxin A, that inhibits light-triggered CF1 ATPase activity.
-
Secretin, porcine TF...
Secretin, porcine TFA (Porcine secretin TFA) is a 27-amino acid peptide, acting on pancreatic acinar cells and ductal epithelial cells stimulating the production of bicarbonate rich fluid.Secretin porcine stimulates pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma.
